Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-022234

President and CEO acquired 14,315 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2020-02-08 Option exercise +5,515 18,020 D
Watts Ryan J. President and CEO 2020-02-08 Option exercise +8,800 26,820 D
Derivatives
Watts Ryan J. President and CEO 2020-02-08 Option exercise · Restricted Stock Units −5,515 5,516 D
Watts Ryan J. President and CEO 2020-02-08 Option exercise · Restricted Stock Units −8,800 26,400 D
Loading xslF345X03/doc4a.xml…